Trials / Completed
CompletedNCT03341832
Efficacy and Safety of NVP-1203 in Patients With Acute Low Back Pain
A Randomized, Double-blind, Active- and Placebo-controlled, Parallel, Multicenter, Phase II an Exploratory Clinical Trial to Evaluate the Efficacy and Safety NVP-1203 in Patients With Acute Low Back Pain
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 91 (actual)
- Sponsor
- NVP Healthcare · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety NVP-1203 in patients with Acute low back pain
Detailed description
This study is a randomized, double-blind, active- and placebo-controlled, parallel, phase II study to evaluate efficacy and safety of NVP-1203 in patients with Acute low back pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | NVP-1203 | oral dose for 7 days |
| DRUG | NVP-1203-R | oral dose for 7 days |
| DRUG | NVP-1203 placebo | oral dose for 7 days |
| DRUG | NVP-1203-R placebo | oral dose for 7 days |
Timeline
- Start date
- 2018-01-31
- Primary completion
- 2019-01-15
- Completion
- 2019-01-15
- First posted
- 2017-11-14
- Last updated
- 2019-09-18
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03341832. Inclusion in this directory is not an endorsement.